GlassScriptPhysician profile
Pawan K Hari
NPI 1336376904
$4,156.86
in general payments reported to CMS, 2019-2025
8 companies · $2,501 in 2025
The $2,501 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $591 · 2021: $68.56 · 2022: $631 · 2024: $246 · 2025: $2,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,188 · Food and Beverage: $535 · Travel and Lodging: $23.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,187.50 |
| Food and Beverage | $535.41 |
| Travel and Lodging | $23.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,309.37 | 2024-2025 | Avvigo Guidance System, Vitalyst |
| Edwards Lifesciences Corporation | $836.66 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Philips North America LLC | $631.11 | 2022 | |
| Abbott Laboratories | $311.16 | 2020-2024 | |
| Shockwave Medical, INC | $48.17 | 2021 | |
| Medtronic, INC. | $20.39 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pawan Hari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.